BRCA1-associated protein 1: Tumor predisposition syndrome and Kury-Isidor syndrome, from genotype-phenotype...

Area of Science:

• Genetics
• Oncology
• Developmental Biology

Background:

• The BAP1 gene encodes a deubiquitinase enzyme critical for DNA repair and apoptosis.
• Germline pathogenic variants in BAP1 are linked to BAP1 tumor predisposition syndrome 1 (BAP1-TPDS1) and Kury-Isidor syndrome (KURIS).
• These distinct, yet related, hereditary conditions arise from dominant BAP1 alterations.

Purpose of the Study:

• To elucidate the genotype-phenotype correlation of BAP1 variants.
• To highlight the clinical significance of differentiating BAP1-TPDS1 from KURY.
• To emphasize the importance of genetic counseling for BAP1 variant carriers.

Main Methods:

• Review of clinical and genetic data from individuals with germline BAP1 variants.
• Comparative analysis of phenotypic manifestations in BAP1-TPDS1 and KURY.
• Assessment of the implications for cancer surveillance and management.

Main Results:

• BAP1-TPDS1 and KURY, though caused by similar BAP1 alterations, present distinct clinical phenotypes.
• These conditions have not been observed concurrently in the same individuals or families, suggesting mutual exclusivity.
• The early-onset, aggressive cancers in BAP1-TPDS1 underscore the need for precise diagnosis.

Conclusions:

• Accurate genetic counseling for BAP1 variants is essential for predicting phenotype and cancer risk.
• Distinguishing between BAP1-TPDS1 and KURY informs personalized surveillance and management strategies.
• Understanding BAP1 variant impact is critical for clinical teams managing affected individuals and families.